++
For further information, see CMDT Part 9-06: Asthma
+++
Essentials of Diagnosis
++
Respiratory symptoms such as wheezing, dyspnea, or cough, which may be variable in time and severity
Variable limitation on expiratory airflow in pulmonary function testing (PFT) or positive bronchoprovocation challenge
+++
General Considerations
++
A chronic disorder of the airways characterized by variable airway expiratory obstruction and hyperresponsiveness
Most common pathogeneses
Airway inflammation with eosinophils, neutrophils, and lymphocytes (especially T cells)
Goblet cell hyperplasia
Plugging of small airways with mucus
Collagen deposition beneath the basement membrane
Bronchial smooth muscle hypertrophy
Airway edema
Mast cell activation
Denudation of airway epithelium
The pathophysiology of asthma is heterogeneous, but a division into T2-high and T2-low endotypes (marked by high and low levels of classic Th2 cytokines, including IL-4, IL-5, and IL-13) has been shown to be important in the selection of targeted biologic therapies
T2-high asthma phenotypes include allergic asthma, late-onset T2-high asthma, and aspirin/NSAID-associated respiratory disease (AERD)
T2-low asthma phenotypes include nonallergic asthma, which tends to occur in adults and be marked by neutrophilic inflammation and variable response to standard therapies
Common aeroallergens
Dust mites
Cockroaches
Cat dander
Seasonal pollens
Nonspecific precipitants
Asthma with persistent airflow limitation thought to be due to airway remodeling
Asthma with obesity refers to prominent respiratory symptoms in patients with obesity with little airway inflammation
Tobacco increases symptoms and decreases lung function
Certain medications (including aspirin and nonsteroidal anti-inflammatory drugs [NSAID]) may be triggers (Table 9–22)
++
++
Affects 8–10% of the population in the United States
Accounts for 10 million office visits, 1.8 million emergency department visits, and more than 3500 deaths annually in the United States
Slightly more common in male children (< 14 years old) and in female adults
There is a genetic predisposition to asthma
Hospitalization rates have been highest among Black persons and children
Death rates for asthma are consistently highest among Black persons aged 15–24 years